ACS Medicinal Chemistry Letters · 2017 · 24 citations · 19 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryNeuropharmacologyStructure-activity RelationshipsBlood-brain Barrier PenetrationGlutamatergic PharmacologyChemical Structure-activity RelationshipsChemical Synthesis Of AnaloguesCns PharmacodynamicsMedicinal Chemistry ApplicationsNeuronal Electrophysiology
Herein, we report the structure–activity relationships within a series of mGlu 7 NAMs based on an N -(2-(1 H -1,2,4-triazol-1-yl)-5-(trifluoromethoxy)phenyl)benzamide core with excellent CNS penetration ( K p 1.9–5.8 and K p,uu 0.4–1.4). Analogues in this series displayed steep SAR. Of these, VU6010608 ( 11a ) emerged with robust efficacy in blocking high frequency stimulated long-term potentiation in electrophysiology studies.
19
Michael Bubser, Thomas M. Bridges, Ditte Dencker et al. · ACS Chemical Neuroscience · 2014 · 155 citations · Full text
Medicine, Neuroscience, Pharmacology +17
Zsuzsanna Callaerts‐Vegh, Tom Beckers, Simon Ball et al. · Journal of Neuroscience · 2006 · 151 citations · Full text
Activation of the mGlu7 receptor elicits antidepressant-like effects in mice
Piotr Brański, Herman van der Putten, Peter J. Flor et al. · Psychopharmacology · 2007 · 140 citations
Medicine, Neuroscience, Pharmacology +11